Management of resistance in other targets beyond ALK and EGFR

Date 07 May 2017
Event ELCC 2017
Session Management of NSCLC with resistance to first line targeted therapy
Topics Complications/Toxicities of treatment
Thoracic malignancies
Supportive and Palliative Care
Presenter Luc Friboulet
Authors L. Friboulet
  • Institut Gustave Roussy, Villejuif/FR